NEW YORK, Aug. 02, 2022 (GLOBE NEWSWIRE) -- A Qualitative Research Study accomplished by Data Bridge Market research's database of 350 pages, titled "Global Biomarkers Market" with 100+ market data Tables, Pie Charts, Graphs & Figures spread through Pages and easy-to-understand detailed analysis. The statistical and numerical data are represented in graphical format for a neat understanding of facts and figures of market research analysis. Furthermore, the superior business report presents the data and information for actionable, most recent, and real-time market insights which make it easier to even take critical business decisions. The market insights gained through this Biomarkers market research analysis report facilitate a more defined understanding of the market landscape, issues that may interrupt in the future, and ways to position a definite brand excellently.
The global Biomarkers Market was valued at USD 43.13 million in 2021 and is expected to reach USD 153.34 million by 2029, registering a CAGR of 14.90% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Request to Download Sample Copy of Biomarkers Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-biomarkers-market&GNW/02Aug2022
Market Overview:-
Biomarkers are referred to as minimally or non-invasive tools. These are integrated with key imaging and data management technologies. These tools are widely utilized in imaging technology to provide clear imaging of oncology tumors and other problems. Biomarkers reduce the chance of radiation exposure during imaging through MRI scan and CT scan.
Some of the major companies which are dealing in the Biomarkers market are
- Enzo Biochem Inc. (US)
- Bio-Rad Laboratories, Inc. (US)
- Merck KGaA (Germany)
- PerkinElmer Inc. (US)
- QIAGEN (Germany)
- Agilent Technologies, Inc. (US)
- Bruker (US)
- Epigenomics AG (Germany)
- MESO SCALE DIAGNOSTICS, LLC (US)
- EKF Diagnostics Holdings plc (UK)
- General Electric Company (US)
- Nexus-Dx (US), LifeSign LLC (US)
- F. Hoffmann-La Roche Ltd (Switzerland)
Recent Development
- F. Hoffmann-La Roche Ltd. launched two cardiac biomarker tests for N-terminal pro-brain natriuretic peptide test (NT-proBNP) and high sensitive cardiac troponin T (cTnT-hs) in April’2021. The cardiac biomarkers assist clinicians in diagnosing heart attacks and manage heart failure better.
- QIAGEN N.V. (Netherlands) launched first FDA-approved tissue companion diagnostic, therascreen KRAS RGQ PCR Kit in May’2021. The diagnostics will identify the KRAS G12C mutation in NSCLC tumors and expand precision medicine options.
Access Full 350 Pages Report @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-biomarkers-market?GNW/02Aug2022
Important Facts about This Market Report:-
- This research report reveals this business overview, product overview, market share, demand and supply ratio, supply chain analysis, and import/export details
- The Industry report captivates different approaches and procedures endorsed by the market key players to make crucial business decisions
- This research presents some parameters such as production value, marketing strategy analysis, Distributors/Traders and effect factors are also mentioned
- The historical and current data is provided in the report based on which the future projections are made and the industry analysis is performed
- The import and export details along with consumption value and production capability of every region is mentioned in the report
- Porter's five forces analysis, value chain analysis, SWOT analysis are some additional important parameters used for the analysis of market growth
- The report provides the clients with the facts and figures about the market on the basis of evaluation of the industry through primary and secondary research methodologies
Opportunities
Furthermore, increase in demand for personalized medicine extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, continuous product innovation will further expand the market.
Biomarkers Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
Prevalence of Cancer
- The increase in the prevalence of cancer across the globe acts as one of the major factors driving the growth of biomarkers market.
Funds and Grants
- The surge in investments in the form of funds and grants for biomarker research accelerate the market growth.
Diagnostic Biomarker Technology
- The inclination from conventional approach of pathophysiology/epidemiology to biomarker studies due to the technological advances further influence the market.
Highlights following key factors:
- Business description – A detailed description of the company’s operations and business divisions
- Corporate strategy – Analyst’s summarization of the company’s business strategy
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats
- Company history – Progression of key events associated with the company
- Major products and services – A list of major products, services and brands of the company
- Key competitors – A list of key competitors to the company
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history
To View Detailed Report Analysis, Visit @ https://www.databridgemarketresearch.com/reports/global-biomarkers-market?GNW/02Aug2022
Global Biomarkers Market Scope and Market Size
The biomarkers market is segmented on the basis of type, application, product type, technology and indication. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Safety
- Efficacy
- Validation
Application
- Diagnostics Development
- Drug Discovery and Development
- Personalized Medicine
- Disease-Risk Assessment
- Others
Product Type
- Consumables
- Services
- Software
Technology
- Safety Biomarkers
- Efficacy Biomarkers
- Validation Biomarkers
Indication
- Cancer
- Cardiovascular Disorders
- Neurological Disorders
- Immunological Disorders
- Others
Strategic Points Covered in Global Biomarkers Market Table of Content:
Chapter 1: Introduction, the basic information of the Global Biomarkers Market & product overview
Chapter 2: Objective of Study and Research Scope of the Biomarkers Market
Chapter 3: Biomarkers Market Dynamics- driving growth factors, disruptive forces, Trends and Challenges & Opportunities
Chapter 4: Market Factor Analysis, Biomarkers Market Value Chain, PESTEL & PORTER Model, Market Entropy, Patent/Trademark Analysis
Chapter 5: Player Analysis; Competitive Landscape, Peer Group Analysis of Biomarkers Market, Strategic Group Analysis, Perpetual Mapping, BCG Matrix & Company Profiling
Chapter 6: Displaying Market Revenue Size by Type, application /vertical or end users, other Segments
Chapter 7: To evaluate the market by countries further broken down by countries
Chapter 8: Research Methodology
Chapter 9: Data Source
Explore Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-biomarkers-market&GNW/02Aug2022
Browse Trending Reports by DBMR
North America Biomarkers Market, By Type (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarker), Product (Consumables, Services, Software, Growth Hormone Therapy), Mechanism (Genetic, Epigenetic, Proteomic, Lipidomic, and Other Mechanisms), Application (Diagnostics Development, Drug Discovery and Development, Personalized Medicine, Disease Risk Assessment, Others), Disease Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Others), Country (U.S., Canada, Mexico, Germany) Industry Trends and Forecast to 2029. https://www.databridgemarketresearch.com/reports/north-america-biomarkers-market
Asia-Pacific (APAC) Biomarkers Market, By Type (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarker), Product (Consumables, Services, Software, Growth Hormone Therapy), Mechanism (Genetic, Epigenetic, Proteomic, Lipidomic, and Other Mechanisms), Application (Diagnostics Development, Drug Discovery and Development, Personalized Medicine, Disease Risk Assessment, Others), Disease Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Others), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific)-Industry Trends and Forecast to 2029 https://www.databridgemarketresearch.com/reports/asia-pacific-biomarkers-market
Europe Biomarkers Market, By Type (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarker), Product (Consumables, Services, Software, Growth Hormone Therapy), Mechanism (Genetic, Epigenetic, Proteomic, Lipidomic, and Other Mechanisms), Application (Diagnostics Development, Drug Discovery and Development, Personalized Medicine, Disease Risk Assessment, Others), Disease Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Others) https://www.databridgemarketresearch.com/reports/europe-biomarkers-market
Cancer Biomarkers Market, By Type (Genetic Biomarkers, Protein Biomarkers, Other Cancer Biomarkers) Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancer, Melanoma, Ovarian Cancer, Liver Cancer, Stomach Cancer and Other Cancer Types), Technology (Imaging Technologies, Omic Technologies, Cytogenetic-Based Tests and Immunoassays), Applications (Drug Discovery and Development, Personalized Medicine, Diagnostics and Others), End User (Hospitals, Academic and Cancer Research Institutes, Ambulatory Surgical Centres and Diagnostic Laboratories)– Industry Trends and Forecast to 2029. https://www.databridgemarketresearch.com/reports/global-cancer-biomarkers-market
North America Cancer Biomarkers Market, By Type (Genetic Biomarkers, Protein Biomarkers, Other Cancer Biomarkers), Product (PSA, HER-2, EGFR, KRAS, Others), Cancer (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancer, Melanoma, Ovarian Cancer, Liver Cancer, Stomach Cancer, Others), Technology (Imaging Technologies, Omic Technologies, Cytogenetic-Based Tests and Immunoassays), Applications (Drug Discovery and Development, Personalized Medicine, Diagnostics and Others), End User (Hospitals, Academic and Cancer Research Institutes, Ambulatory Surgical Centers and Diagnostic Laboratories), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2029. https://www.databridgemarketresearch.com/reports/north-america-cancer-biomarkers-market
Europe Cancer Biomarkers Market, By Product (Consumables, Services, Software, Growth Hormone Therapy), Type (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers), Profiling Technologies (OMICS, Imaging Technology, Immunoassays, Cytogenetics and Bioinformatics), Service (Sample Preparation, Assay Development, Biomarkers & Testing), Application (Diagnostics Development, Drug Discovery and Development, Personalized Medicine, Disease-Risk Assessment, Others), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Others), Country (Germany, France, U.K., Spain, Italy, Russia, Netherlands, Turkey, Belgium, Switzerland, Rest of Europe) Industry Trends and Forecast to 2027 https://www.databridgemarketresearch.com/reports/europe-cancer-biomarkers-market
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com
